Knowledge, acceptance and willingness to pay for malaria vaccine among residents of a semi-urban community in Kaduna State, North-western Nigeria

Main Article Content

Hanan Faridah Yusuf
Auwal Garba Suleiman https://orcid.org/0000-0002-0242-7978
Shefaatu Shehu
Umar Yahaya
Suleiman Usman
Usman Hamisu Indabo

Keywords

malaria, malaria vaccine, malaria control, R21, RTS,S, Nigeria, NMEP

Abstract

Background: Malaria is a life-threatening parasitic infection associated with high morbidity and mortality in endemic regions. The World Health Organization (WHO) has approved two malaria vaccines for use in children and as countries begin the phased rollout of these vaccines, uncertainties around community awareness, attitudes, and willingness to accept the vaccines remain.
Methodology: This study used a multistage sampling to select 200 mostly female caregivers of children under the age of five years in Samaru, a semi-urban community in Kaduna State, North-western Nigeria. Data on knowledge, attitude, and willingness to accept the malaria vaccine was obtained using a structured questionnaire and analysed using IBM SPSS Statistics. Knowledge and attitude were scored and graded into good and poor categories. The data was presented using frequency tables and a chi-square test was used to check for associations between willingness to accept malaria vaccine and relevant variables. A P value < 0.05 was considered statistically significant.
Results: The majority of the respondents were females (65.5%) and married (93.0%), with a mean age of 33.1 (±9.3) years. Fifty-seven (28.5%) caregivers heard of the malaria vaccine mostly through healthcare workers and traditional media, while 39 (19.5%) showed good knowledge of the vaccine. A total of 194 (97.0%) had a good attitude towards the vaccine, 188 (94.0%) were willing to accept the vaccine, and 176 (88.0%) said they were willing to pay for it. Factors associated with vaccine acceptance included the caregiver being vaccinated as a child, having at least one child who is vaccinated, and having a good attitude toward the vaccine.
Conclusion: Despite low awareness, willingness to accept the malaria vaccine was high in the community. It is recommended that immediate steps be taken by relevant stakeholders to educate the public and begin the rollout of the vaccine to avoid the spread of rumours and misconceptions.

Abstract 264 | PDF Downloads 154 EPUB Downloads 14

References

1. National Malaria Elimination Programme. National Malaria Strategic Plan 2021-2025. Abuja: Federal Government of Nigeria; 2020. p. 1–106.

2. World Health Organization. World Malaria Report 2024. Geneva (Switzerland); 2024.

3. National Bureau of Statistics. Demographic Statistics Bulletin 2022. Abuja; 2023.

4. National Malaria Elimintion Programme. Nigeria Malaria Indicator Survey. Abuja; 2021.

5. President’s Malaria Initiative. Nigeria Malaria Operational Plan FY 2015. United States: President’s Malaria Initiative; 2015. p. 1–75.

6. World Health Organization. Malaria Vaccines (RTS,S and R21) [Internet]. Q&A. 2024 [cited 2024 Sep 20]. p. 1–3. Available from: htts://www.who.int/news-room/questions-and-answers/item/q-a-on-rts-s-malaria-vaccine

7. World Health Organization. 18 Million Doses of First-ever Malaria Vaccine Allocated to 12 African Countries for 2023-2025: Gavi, WHO and UNICEF [Internet]. Joint News Release. 2023 [cited 2024 Sep 20]. p. 1–4. Available from: https://www.who.int/news/item/05-07-2023-18-million-doses-of-first-ever-malaria-vaccine-allocated-to-12-african-countries-for-2023-2025-gavi-who-and-unicef

8. GAVI. Everything You Need to Know about the Malaria Vaccine [Internet]. Vaccines Work. 2024 [cited 2024 Dec 12]. p. 1–9. Available from: https://www.gavi.org/vaccineswork/everything-you-need-know-about-malaria-vaccine

9. Otieno L, Mendoza YG, Adjei S, Agbenyega T, Agnandji TS, Aide P, et al. Safety and Immunogenicity of the RTS,S/AS01 Malaria Vaccine in Infants and Children Identified as HIV-infected During a Randomized Trial in Sub-Saharan Africa. Vaccine. 2020;38(4):897–906. doi: 10.1016/j.vaccine.2019.10.077

10. Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine Hesitancy: Causes, Consequences and a Call to Action. Am J Prev Med. 2015;49(6):391–8. doi: 10.1016/j.amepre.2015.06.009

11. Simas C, Larson HJ. Overcoming Vaccine Hesitancy in Low-income and Middle-income Regions. Nat Rev. 2021;7(41):1–2. doi: 10.1038/s41572-021-00279-w

12. Guzman-Holst A, DeAntonio R, Prado-Cohrs D, Juliao P. Barriers to Vaccination in Latin America: A Systematic Literature Review. Vaccine. 2020;38(3):470–81. doi: 10.1016/j.vaccine.2019.10.088

13. Ughasoro MD, Esangbedo DO, Tagbo BN, Mejeha IC. Acceptability and Willingness-to-Pay for a Hypothetical Ebola Virus Vaccine in Nigeria. PLoS Negl Trop Dis. 2015;9(6):1–15. doi: 10.1371/journal.pntd.0003838

14. Aboh EA, Giwa FJ, Giwa A. Microbiological Assessment of Well Waters in Samaru, Zaria, Kaduna State, Nigeria. Ann Afr Med. 2015;14(1):32–8. doi: 10.4103/1596-3519.148732

15. Chia MA, Oniye SJ, Swanta AA. Domestic Water Quality Assessment: Microalgal and Cyanobacterial Contamination of Stored Water in Plastic Tanks in Zaria, Nigeria. Eur J Sci Res. 2013;110(4):501–10. Available from: http://www.europeanjournalofscientificresearch.com

16. Sufiyan MB, Umar AA, Shugaba A. Client Satisfaction with Antenatal Care Services in Primary Health Care Centres in Sabon Gari Local Government Area, Kaduna State, Nigeria. J Community Med Prim Heal Care. 2013;25(1):12–22.

17. Lwanga S, Lemeshow S. Sample Size Determination in Health Studies: A Practical Manual, 1991. 1st ed. World Health Organization, Geneva. England: Macmillan; 1991. 88 p.

18. Abdulkadir BI, Ajayi IO. Willingness to Accept Malaria Vaccine among Caregivers of Under-5 Children in Ibadan North Local Government Area, Nigeria. Malar World J. 2015;6(2):1–10. Available from: www.malariaworld.org.

19. Chukwuocha UM, Okorie PC, Iwuoha GN, Ibe SN, Dozie IN, Nwoke BE. Awareness, Perceptions and Intent to Comply with the Prospective alaria vacVcine in Parts of South Eastern Nigeria. Malar J. 2018;17(187):1–7. doi: 10.1186/s12936-018-2335-0

20. Wagnew Y, Hagos T, Weldegerima B, Debie A. Willingness to Pay for Childhood Malaria Vaccine among Caregivers of Under-Five Children in Northwest Ethiopia. Clin Outcomes Res. 2021;13(1):165–74. doi: 10.2147/CEOR.S299050

21. Musa-Booth T, Enobun B, Agbomola A, Shiff C. Knowledge, Attitude and Willingness to Accept the RTS,S Malaria Vaccine among Mothers in Abuja, Nigeria. Ann Afr Med. 2021;4(128):1–7. doi: 10.4081/aamr.2021

22. Onyekachi O, Abana CC, Nwajiobi FO. Prevalence of Malaria and Willingness to Accept Malaria Vaccine amongst Parents, Guardians and Caregivers of Children under 5 Years. Asian Res J Curr Sci. 2021;3(1):36–50.

23. Romore I, Ali AM, Semali I, Mshinda H, Tanner M, Abdulla S. Assessment of Parental Perception of Malaria Vaccine in Tanzania. Malar J. 2015;14(355):1–6. doi: 10.1186/s12936-015-0889-7

24. Maduka UD, Adaobi BOI, Okafor HU. Acceptance of Malaria Vaccine by a Rural Community in Nigeria. Niger J Med. 2018;27(3):199–204.

25. Sulaiman SK, Musa MS, Tsiga-Ahmed FI, Dayyab FM, Sulaiman AK, Bako AT. A Systematic Review and Meta-analysis of the Prevalence of Caregiver Acceptance of Malaria Vaccine for Under-five Children in Low-income and Middle-income Countries (LMICs). PLoS One. 2022;17(12):1–15. doi: 10.1371/journal.pone.0278224

26. Chinawa AT, Ossai EN, Onukwuli VO, Nduagubam OC, Uwaezuoke NA, Okafor CO, et al. Willingness to Accept Malaria Vaccines amongst Women Presenting at Outpatient and Immunization Clinics in Enugu State, Southeast Nigeria. Malar J. 2024;23(117):1–10. doi: 10.1186/s12936-024-04914-1

27. Immurana M, Boachie MK, Klu D, Dalaba MA, Manyeh AK, Alhassan RK. Determinants of Willingness to Accept Child Vaccination against Malaria in Ghana. Int J Health Plann Manage. 2022;37(3):1439–53. doi: 10.1002/hpm.3406

Most read articles by the same author(s)